Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03978806 · ClinicalTrials.gov registry record · NA
Prosperando: Fostering Resilience on Dialysis
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT03978806 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 139 participants.
The verdict
NCT03978806, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
Latinos with End-Stage Renal Disease (ESRD) represent 17% of the US adult ESRD community and suffer a disproportionate burden of social challenges that impacts their well-being. With support from the Amos award from the Robert Wood Johnson Foundation (RWJF), the investigators assessed the feasibility of a 1-arm intervention of a 5-visit lay Peer Navigator intervention to support Latino ESRD patients with social challenges and adherence (using motivational interviewing \& patient activation). This trial will build on the Amos work as a small Randomized Controlled Trial (RCT). The overall aims of this proposal are to: 1) engage key operational and clinical stakeholders early-on to develop a Peer Navigator-intervention; 2) conduct a pilot RCT of the peer navigator intervention versus standard care to test feasibility and acceptability; and 3) assess the efficacy of the intervention on interdialytic weight gain (primary outcome) as well as health-related quality of life, patient activation, and hemodialysis adherence (secondary outcomes).
Interventions
- BEHAVIORAL Active Comparator: peer navigator
- OTHER Placebo Comparator: Control Arm (standard of care)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2024-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03978806
The ClinicalTrials.gov registry entry for NCT03978806 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Comparator: peer navigator is the first listed.
NCT03978806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03978806 about?
NCT03978806 is a clinical study titled "Prosperando: Fostering Resilience on Dialysis". Latinos with End-Stage Renal Disease (ESRD) represent 17% of the US adult ESRD community and suffer a disproportionate burden of social challenges that impacts their well-being. With support from the Amos award from the Robert Wood Johnson Foundation (RWJF), the investigators assessed the feasibilit...
What is the current status of trial NCT03978806?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2020-10-05. Estimated completion is 2024-07-07.
What interventions are being tested in trial NCT03978806?
The interventions under investigation include: Active Comparator: peer navigator (BEHAVIORAL), Placebo Comparator: Control Arm (standard of care) (OTHER).
Who is sponsoring clinical trial NCT03978806?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.